Patients Prefer Pens With Auditory and Sensory Confirmation

From the Spring Research Guide

| Apr 1, 2006

Because people with diabetes sometimes suffer from visual impairment as well as reduced manual dexterity, Japanese researchers assessed the reliability of dose selection and setting of five insulin devices by patients using auditory and sensory confirmation.

A total of 48 patients (30 men, 18 women) were randomized to test the following pen devices:

  • NovoPen 3 (Novo Nordisk)
  • HumaPen Ergo (Eli Lilly)
  • Humalog Pen (Eli Lilly)
  • InnoLet (Novo Nordisk), and
  • FlexPen(Novo Nordisk)

The researchers found that “Significantly more patients detected an auditory confirmation of dose setting when using the NovoPen 3 compared with the Humalog Pen, HumaPen Ergo and InnoLet.”

They add that the audible click for the FlexPen was also heard by more patients than for the Humalog Pen and HumaPen Ergo.

All patients found that the FlexPen provided the most physical sensory confirmation. Patients reported having the most confidence about setting the correct dose with the NovoPen3 and the FlexPen. These two pens were also found to be the most reliable for dose setting.

Sound recordings showed that the NovoPen 3 produced the loudest clicks when setting a dose.

“The clarity of the click when setting a dose on an insulin delivery device can affect the patient’s confidence in selecting the correct dose,” the researchers say.

Diabetes Technology and Therapeutics, August 2005

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Insulin, Novo Nordisk, Pens, Professional Issues

Diabetes Health Professional
Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.